hoe 33342 has been researched along with Extravasation of Contrast Media in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, M; Dhubhghaill, SN; Farrar, GJ; Humphries, M; Humphries, P; Kenna, PF; Kiang, AS; Nguyen, AT; Tam, L | 1 |
| Allegrini, PR; Drevs, J; Esser, N; Fuxius, S; Hennig, J; Hugenschmidt, H; Konerding, MA; Marmé, D; Müller-Driver, R; Unger, C; Wittig, C; Wood, J | 1 |
2 other study(ies) available for hoe 33342 and Extravasation of Contrast Media
| Article | Year |
|---|---|
Reversible and size-selective opening of the inner Blood-Retina barrier: a novel therapeutic strategy.
Topics: Animals; Benzimidazoles; Blood-Retinal Barrier; Claudin-5; Cryoultramicrotomy; Extravasation of Diagnostic and Therapeutic Materials; Eye Diseases; Gadolinium DTPA; Injections; Magnetic Resonance Imaging; Membrane Proteins; Mice; Mice, Inbred C57BL; Molecular Weight; Perfusion; RNA Interference; RNA, Small Interfering | 2010 |
PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging.
Topics: Angiogenesis Inhibitors; Animals; Benzimidazoles; Blood Vessels; Capillary Permeability; Carcinoma, Renal Cell; Enzyme Inhibitors; Extravasation of Diagnostic and Therapeutic Materials; Female; Fluorescent Dyes; Heterocyclic Compounds; Kidney Neoplasms; Magnetic Resonance Angiography; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Organometallic Compounds; Phthalazines; Pyridines; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Regional Blood Flow | 2002 |